Bevacizumab for the Treatment of Glioblastoma

Por Gil-Gil, Miguel J., Mesia, Carlos, Rey, Montserrat, Bruna, Jordi
Publicado em 2013

Risk of Ischemic Stroke Associated With Calcium Supplements With or Without Vitamin D: A Nested Case‐Control Study

Por de Abajo, Francisco J., Rodríguez‐Martín, Sara, Rodríguez‐Miguel, Antonio, Gil, Miguel J.
Publicado no J Am Heart Assoc (2017)

Long-term response to first-line bevacizumab-based therapy in patients with metastatic breast cancer: results of the observational “LORENA” study

Por Redondo, Andrés, Ramos Vázquez, Manuel, Manso, Luis, Gil Gil, Miguel J, Garau Llinas, Isabel, García-Garre, Elisa, Rodríguez, César A, Chacón, José Ignacio, López-Vivanco, Guillermo
Publicado no Onco Targets Ther (2018)

Trends in the surgical procedures of women with incident breast cancer in Catalonia, Spain, over a 7-year period (2005–2011)

Por Escribà, Josep M, Pareja, Laura, Esteban, Laura, Gálvez, Jordi, Melià, Angels, Roca, Laura, Clèries, Ramon, Sanz, Xavier, Bustins, Montse, Pla, María J, Gil, Miguel J, Borrás, Josep M, Ribes, Josepa
Publicado em 2014

Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients

Por Molina, David, Pérez-Beteta, Julián, Martínez-González, Alicia, Sepúlveda, Juan M., Peralta, Sergi, Gil-Gil, Miguel J., Reynes, Gaspar, Herrero, Ana, De Las Peñas, Ramón, Luque, Raquel, Capellades, Jaume, Balaña, Carmen, Pérez-García, Víctor M.
Publicado no PLoS One (2016)